Review and future report

Barry Dawes has supplies this summary
Key Points

• MPS-listed DongFang Modern moving higher again.
• Market leader in Citrus and Camelia Plantation revenues in China
• Fruit and Camelia products sales >237,000t in 2017
• 21 plantations covefring 10,763 hectares
• FY17 revenues A$214m
• FY17 earnings A$93.9m
• 70% interest acquired in Australian health supplements business using camelia products
• Acquisition likely to add A$~A$3m to net earnings in FY18
• Total FY18 earnings likely to now be well over A$100m

MPS (as Paradigm) listed DFM in 2015 in a A$39m ASX IPO at A$1.00.

The stock reached A$2.50 and a market cap of A$1000m in 2016 before weakening into 2017.

The quality of the operations is very high and is deserving of a far higher PER than the current prospective 5.7x.

The acquisition will provide some long term high margin high growth synergies and add to EPS.
Please attend the near term AGM to flesh out new deal.with all the cash on hand expect more like it.
An opportunity to leverage fruit production and profits.
Oh remember there is no local tax on fruit production from China farms.
The numbers above are exceptional and repeatable.
the rerate should continue